DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹139 Cr | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹139 Cr |
Mar2023 | ₹-936 Cr |
Mar2022 | ₹-70 Cr |
Mar2021 | ₹1,275 Cr |
Mar2020 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹139 Cr | Positive | |
Mar2023 | ₹-936 Cr | Negative | |
Mar2022 | ₹-70 Cr | Negative | |
Mar2021 | ₹1,275 Cr | Positive | |
Mar2020 | ₹-24 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹99,673.3 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -4.1% |
-10.8% |
9.5% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses